Visit https://www.peervoice.com/ZSY860 to view the entire programme with slides. After completing “Immunotherapy for Advanced NSCLC Today and Tomorrow: Mining the Evidence to Refine Care”, participants will be able to: Discuss the evidence with current and emerging therapies for advanced NSCLC and implications for clinical practice; Outline factors that may guide treatment decisions for patients with advanced NSCLC in Canadian practice; Identify optimal first-line treatment approaches for patients with advanced NSCLC, based on patient and disease factors.